Page 12 - WNS 2022 Program Book-Final version_Neat

Statement:
Before the program, anyone in control of the educational content of this activity will disclose
the existence of any financial interest and/or the relationship they or their significant other
have with the manufacturer(s) of any commercial product(s) to be discussed during their
presentation.
Disclosures will be included in the final program.
Speakers, paper presenters/authors and staff (and the significant others of those mentioned)
who have disclosed a relationship* with commercial interests whose products may
have a relevance to their presentation are listed below.

NAME DISCLOSURE TYPE OF RELATIONSHIP

Juan Fernandez-
Miranda MD
Samer Ghostine, MD

Leucadia Therapeutics (CMO,Research support,
Stock)

Avail, Cerenovus, Medtronic, Stryker (Consultant)
Baxter (Consultant); Brainlab, Stryker (Industry Grant)
Speakers, paper presenters/authors and staff (and the significant others of those men-
tioned) who have reported they do not have any relationships with commercial interests:
Moustapha Abou-Samra* Barbara Lazio David Pitkethly* Mark Sedrak
Karol Budohoski Jay Morgan* Mara Pitkethly* David Westra
Justin Dye* Nigel Nicholson J. Adair Prall* Benjamin Yim
Ciara Harraher* John O'Meara Donald Prolo* Jacob Young
Won Kim Arjun Pendharkar Laura Prolo Joshua Catapano
Deborah Henry* Michael Karsy Mohamed Macki
12